Tsontcho Ianchulev - Apr 21, 2025 Form 4/A - Amendment Insider Report for EYENOVIA, INC. (EYEN)

Role
Director
Signature
/s/ Tsontcho Ianchulev
Stock symbol
EYEN
Transactions as of
Apr 21, 2025
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/29/2025, 07:52 PM
Date Of Original Report
Apr 23, 2025
Previous filing
Jun 14, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYEN Common Stock, par value $.0001 Award $0 +5K +97.62% $0.00 10.1K Apr 21, 2025 Direct F1, F2
holding EYEN Common Stock, par value $.0001 7.58K Apr 21, 2025 By Private Medical Equity, Inc. F3
holding EYEN Common Stock, par value $.0001 75 Apr 21, 2025 By The Meliora Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that will fully vest upon the closing of the Issuer's proposed business combination with Betaliq, Inc. Vesting is subject to the Reporting Person's continued service to the Issuer.
F2 On January 31, 2025, the Issuer effected a reverse stock split of its common stock at a ratio of 1-for-80 (the "Reverse Split"). The Reporting Person's ownership of the Issuer's securities has been adjusted to reflect the impact of the Reverse Split.
F3 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Remarks:

This Form 4/A is being filed to correct a clerical error in the original Form 4 filed on 04/23/2025. The original filing incorrectly reported the amount of securities beneficially owned directly by the Reporting Person. All other information in the original filing remains unchanged.